The majority of antigenic peptides exhibit restriction in their interaction with the MHC molecules on antigen-presenting cells of different haplotypes. Certain peptides, however, are 'permissive': they bind strongly to different MHC molecules and are selected as the immunodominant epitopes by animals using these MHC gene products. Here we show for the first time that several peptides from four regions of the sequence of human S-antigen (H-SAg), a retinal-specific protein, demonstrate high levels of permissiveness. Each of these peptides was found to be immunodominant in at least some of four inbred rat strains and five cynomolgus monkeys, immunized with whole H-SAg. Moreover, some of these peptides were recognized by lymphocytes from four normal controls and four patients with uveitis who responded against the H-SAg molecule. On the other hand, the permissive peptides stimulated marginal or no response in cultures of Lewis rats injected with adjuvant alone, or rat and human cell lines specific to other antigens, thus demonstrating that these peptides do not carry any non-specific mitogenic activity. One peptide, 29, which was found immunodominant in the monkeys, the uveitis patients and Lewis rats, is highly immunopathogenic in this rat strain. No good correlation between immunodominance and immunopathogenicity was found with other H-SAg peptides. The finding of cross-species permissiveness among peptides of H-SAg and similar observations with myelin proteins suggest that permissiveness could be quite prevalent among peptides of immunopathogenic antigens.
Introduction
The immune response against a whole protein is targeted by T cells restricted by these MHC molecules (4,10-14). The majority of permissive peptides have been found in the toward a small number of peptide determinants, the immunodominant epitopes, while the majority of the protein's sequence of microbial proteins such as viral (10), mycobacterial (11,12) or plasmodial (13,14) components, or tetanus sequences are 'cryptic' and do not elicit any detectable response (1, 2) . A pivotal property of immunodominant peptoxin (4,10). In addition, several peptides of the myelin basic protein (MBP) (5) and proteolipid protein (PLP) (15) were tides is their strong affinity to the MHC molecules on antigenpresenting cells (APC) of the responding animal (1, (3) (4) (5) . Due found to be permissive in their binding to different MHC molecules. Moreover, a number of these peptides were found to the polymorphism of MHC molecules, the majority of immunogenic peptides bind strongly to only a single or a to be encephalitogenic in experimental animals (15-17) and to be recognized by lymphocytes from patients with multiple small number of MHC molecules (6-9). Certain peptides, however, were found to exhibit 'permissiveness' or 'promiscusclerosis (5,18-20).
The retina contains at least four tissue-specific proteins that ity' in their capacity to bind to a large number of different MHC molecules, of one or more species, and to be recognized are immunopathogenic and induce intraocular inflammation ('uveitis') when injected to experimental animals (21) (22) (23) . One in animals immunized with the whole molecule, as well as those that are recognized by human donors who respond of these proteins, designated 'S-antigen' (SAg) or 'arrestin', is a 48 kDa glycoprotein that plays a pivotal role in the vision against this protein. Forty overlapping peptides that span the entire sequence of H-SAg were tested and several peptides process (24, 25) . SAg is highly uveitogenic in several species (21, 22, 24, 26, 27) and is thought to be a target for immunopaexhibited permissiveness by being immunodominant in different rat strains, several individual monkeys, as well as some thogenic processes that mediate uveitic conditions in humans (21, 22, 28) . In accord with this notion, a large portion of human donors. patients with uveitis were found to respond to SAg by the lymphocyte proliferation assay (21, 22, (28) (29) (30) . In addition, Methods similar to observations with the response to MBP (18,31), cellular responses to SAg were also detected in normal Antigens controls (32, 33) .
The goal of the present study was to identify peptide Recombinant human SAg (rH-SAg) was prepared as described elsewhere (34) , purified protein derivative (PPD) determinants of human SAg (H-SAg) that are immunodominant containing Mycobacterium tuberculosis H37 Ra, at 2.5 mg/ ml (Difco, Detroit, MI). Control rats were injected with the adjuvant emulsified with saline. The monkeys were immunized with the antigen, emulsified with Hunter's adjuvant (CytRx, Norcross, GA), at 40 µg/kg body weight, injected into the nape of the neck. All animal procedures conformed to Institutional guidelines and the ARVO Resolution on Use of Animals in Research.
Human subjects After informed consent was obtained, blood samples from eight male donors with positive lymphocyte response against whole rH-SAg were obtained. Kozhich respectively. These two cell lines were established Biosystems (Foster City, CA, USA). The peptides were syntheas described elsewhere (36,37). A human lymphocyte cell sized by solid-phase chemistry using t-butyloxycarbonyl line specific to PPD was prepared from the peripheral blood derivatives of the amino acids and purified by HPLC to at of normal donor 1, as detailed elsewhere (33) . The proliferative least 95% purity.
responses of the rat and human cell lines were determined as detailed by Hu et al. (37) and Hirose et al. (33) respectively. Animals and immunization ized with rH-SAg monkeys, weighing 2.5-3 kg, were provided by the NIH Animal Facility. The rats were injected into one hind footpad Groups of rats of four inbred strains were immunized with rHSAg and examined for the development of experimental with 50 µg rH-SAg, emulsified with complete Freund's adjuvant autoimmune uveoretinitis and cellular immunity against rHcytes from four of these animals against the 40 peptides are summarized in Fig. 3 . All four monkeys responded vigorously SAg and the 40 overlapping peptides of its sequence. Severe ocular inflammation developed in the Lewis rats, less intense to the whole SAg preparation and to a relatively large number of peptides. Although there are differences among individual disease was seen in eyes of ACI and Buffalo rats, whereas no ocular changes were detected in the BN rats. The rat animals in their response to the 40 peptides, it is noteworthy that certain peptides were immunodominant in all four monstrains differed also in the intensity of their cellular response to the 40 peptides (Fig. 2) 29 and 30) . Moreover, several peptides were immunodominant in two or two concentrations, whereas the responses to the other peptides were usually much lower at 10 than at 100 µg/ml. three rat strains and peptide 8 was immunodominant in all four rat strains.
The effect of peptide concentration was further examined by measuring the proliferative responses of lymphocytes from the fifth immunized monkey (3850) against nine stimulatory Proliferative responses of peripheral blood lymphocytes (PBL) peptides at four concentrations, 0.1, 1, 10 and 100 µg/ml from immunized monkeys (Fig. 4) . As seen in Fig. 4 , only two peptides, 29 and 30, were stimulatory at all four concentrations; peptides 1, 3 and 8 All five monkeys immunized with rH-SAg developed severe intraocular inflammation. Proliferative responses of lymphoagain showed similar activity at 10 and 100 µg/ml, but had no significant effect at the lower concentrations, while peptides mitogenicity by the 40 peptides was further demonstrated by the finding that the peptides had no effect in cultures of 5, 13, 18 and 19 were strongly stimulatory only at 100 µg/ml.
cell lines of human lymphocytes specific to PPD, or rat Proliferative responses of human PBL lymphocytes specific for H-SAg peptide 35, or peptide 1181-1191 of bovine IRBP ('R15') ( Fig. 8) . On the other hand, the PBL from four healthy donors and four patients with uveitis, that responded against rH-SAg, were also tested for their cell line lymphocytes responded vigorously to their specific antigens (including H-SAg peptide 35), as well as to the proliferative response against the 40 overlapping peptides of this protein. The patterns of response of the four healthy mitogens Con A (rat cells) or PHA (human cells) (Fig. 8) . donors (Fig. 5) were quite variable, with only one peptide, 18, being stimulatory to lymphocytes of all four individuals. Discussion Other peptides, that stimulated lymphocytes of two or three donors, included 3, 8, 13 and 30. Much higher uniformity was Data recorded here show that certain regions of the H-SAg sequence harbor peptide determinants that were selected for observed in the pattern of response of the uveitis patients (Fig. 6) , with all four individuals responding well against immunodominance by the immune systems of animals with different MHC make-ups. Three of these regions, at sequences peptides 1, 8, 18 and 29. Moreover, patients 1, 2 and 3 responded with a remarkably uniform pattern, that closely 61-90, 171-200 and 281-310, encompass peptides that were immunodominant in at least some of the four rat strains resembled that seen in the monkeys' responses (Fig. 3) . Despite the similarity in their pattern of peptide recognition, (Fig. 2) , the five monkeys (Figs 3 and 4) and the eight human donors (Figs 5 and 6 ). In addition, sequence 1-20 was found the four patients were found to differ in their MHC haplotypes (Table 1) . to be recognized by all H-SAg immunized monkeys and the majority of human donors. The highest level of permissiveness Permissive peptides of H-SAg do not carry non-specific was exhibited by peptide 8, that was dominant in all four rat mitogenic properties strains, all monkeys and seven of the eight human donors. Also of note are peptide 18, that was recognized by all human To test whether the highly permissive peptides stimulate lymphocytes by a non-specific mitogenic activity, the 40 Hdonors and the five monkeys, and peptides 29 and 30, that stimulated vigorous responses by lymphocytes of Lewis rats, SAg peptides were added (at 100 µg/ml) to cultures of lymph node cells of control Lewis rats injected with the adjuvant all monkeys and three of the uveitis patients. The peptides used in the present study consisted of 20 emulsified with saline. As seen in Fig. 7(A) , no proliferation was stimulated by most peptides and only a slight response amino acids each and it is possible that different portions of some of these peptides were selected as the dominant was detected in cultures incubated with peptide 8. In contrast, lymph node cells from rats immunized with rH-SAg responded epitopes by immune systems of different animals. Additional studies, with truncated peptides, should be carried out, with high SI levels against peptides 29, 30, 32 and 33, at both 100 and 10 µg/ml (Fig. 7B and C) . The lack of non-specific therefore, in order to analyze the fine specificity of the four patients with uveitic conditions. The peptides were tested at 100 four normal donors. The peptides were tested at 100 µg/ml and the µg/ml and the assay as well as the patients' conditions are described assay is described in Methods rH-SAg, at 10 and 2 µg/ml, were as follows: 1, 8.1 and 9.9; 2, 15.5 1, 6.9 and 12.1; 2, 6.7 and 4.4; 3, 3.6 and 3.6; 4, 5.5 and 5.0. and 24.3; 3, 5.5 and 10.3; 4, not determined.
lymphocyte response and to examine the possible existence of nested multiple epitopes within the highly permissive minimal stimulatory concentration in culture. This parameter was investigated in the present study with monkey lymphopeptides of H-SAg. Nonetheless, it is remarkable that the same restricted regions of the H-SAg molecule were selected cytes. Several peptides were found to stimulate lymphocyte responses only at 100 µg/ml but not at 10 µg/ml (Fig. 3) . for immunodominance by immune systems that differ markedly in their MHC make-up.
Moreover, only peptides 29 and 30 stimulated significant responses when tested at the low concentrations of 1.0 and 0.1 The MHC molecules reactive with the permissive H-SAg peptides included those of three species and a variety of µg/ml (Fig. 4) . The relationship between immunodominance of peptides and their minimal stimulatory concentration in culture different haplotypes within the species. Lewis, ACI, Buffalo and BN rats belong to four haplotypes, l, avl, b and n was depicted in our previous study with rats immunized with peptides derived from another retinal protein, IRBP. The respectively, with considerable differences in their RT1 antigens (38). No information could be obtained about the genetic minimal stimulatory concentration of an immunodominant peptide was lower by at least four or five orders of magnitude make-up of the five cynomolgus monkeys, but the similar pattern of their response to the H-SAg peptides could be due than those of cryptic peptides of the same protein (39). Our observations are in accord with the finding that a direct to genetic resemblance. Minimal homology was noted among the haplotypes of the eight human donors (Table 1) and correlation exists between immunodominance of peptides and their affinity toward MHC molecules (1, 3-5); it is assumed even among those of the three patients who exhibited close similarity in their lymphocyte responses to the 40 peptides that high affinity enables peptides to effectively bind to the APC and provide stimulation even at low concentrations. (Fig. 6) .
Remarkable differences were seen among the levels of Additional studies are being set up to measure the affinity of the H-SAg peptides toward MHC molecules and compare response stimulated by the immunodominant peptides (Figs  2-6 ). In addition, the peptides differed markedly in their this feature with their immunodominance. ( Fig. 6) . A high level of uveitogenicity in Lewis rats was also b Based on data reported elsewhere (40) .
exhibited by peptide 19 (40) , that was cryptic in Lewis rats, but was immunodominant in ACI rats (Fig. 2) and in the tested monkeys (Fig. 3) . On the other hand, no uveitogenicity was demonstrated in Lewis rats by peptide 8, that was moderately in Lewis rats (41) , stimulated just a minimal response in lymphocyte cultures of these animals ( Fig. 2) and showed a immunodominant in these rats (Fig. 2) and showed the highest level of permissiveness, and by peptides 1 and 18, that were low level of immunodominance in only one human donor (Normal 1, Fig. 5 ). dominant in monkeys (Fig. 3) hand, the pattern of response of the patients to the 40
